Arlo Technologies: Record Margins And Raised Guidance, But The Stock Has Run Ahead

Arlo Technologies (NYSE: ARLO) delivered its best quarter yet. Revenue topped $156M, non-GAAP gross margin hit 50.1%, product losses nearly vanished, and management raised 2026 guidance to $580–$600M. The stock surged over 6% following the August 6 release, and an analyst raised the price target to $17. The operational momentum is real.

The rating, though, hasn't moved. The stock has already re-priced much of this improvement, operating expenses are still outpacing revenue growth, and the margin story depends on tariffs and product mix staying cooperative. I'm maintaining a Hold.

What Changed

Arlo beat on both sides of the income statement for the fourth consecutive quarter. Q2 revenue came in at $155.94 million, up 20.5% year over year and above the consensus estimate of roughly $149 million. Non-GAAP diluted EPS was $0.28 per share versus the $0.20 estimate — a 40% surprise.

The headline that deserves more attention than the beat itself is margin. Non-GAAP gross margin reached 50.1%, a company record, up roughly 480 basis points from a year ago. Adjusted EBITDA — earnings before interest, taxes, depreciation, and amortization, a rough proxy for operating cash generation — climbed 70.3% to $30.6 million, or roughly 20% of revenue. For a company that was posting product gross losses of nearly $8 million at this point last year, that is a meaningful inflection. Products posted a negligible $0.2 million loss this quarter versus a $7.9 million loss year ago.

Two drivers explain the margin expansion. First, subscriptions and services — the high-margin part of the business — now represent 59.7% of total revenue, up from roughly 56% a year ago. Subscription revenue grew 19% to $93.0 million, with a segment gross margin of 81.1%. Second, a better hardware mix, with fewer low-margin legacy products dragging the product segment down.

The Subscription Engine

Paid accounts hit 6.3 million, up 23.2% year over year. That's the right direction. The concern is that annual recurring revenue — the run-rate subscription revenue Arlo collects annually — grew only 15.6% to $365 million. Paid accounts are growing faster than the revenue those accounts generate. That means average revenue per paid account is declining, or a disproportionate share of new accounts are on lower-tier plans.

It's an early-stage trend, but one worth watching. If Arlo can't move users up the plan stack, subscription growth eventually hits a ceiling even as account count keeps climbing.

Operating Expenses Are The Leak

Revenue grew 20.5%. Operating expenses grew 29.6%. That is the wrong direction.

Total operating expenses reached $72.8 million, with general and administrative costs adding $6.8 million year over year and research and development adding $5.2 million. The result: GAAP operating income of just $2.5 million, or a 1.6% margin — essentially flat year over year despite the gross margin expansion. All the top-line and margin improvement was absorbed by the expense build.

GAAP net income was $3.0 million and GAAP EPS was a flat $0.03 versus the prior year. The divergence between GAAP and non-GAAP earnings is wide, in part because of stock-based compensation and amortization tied to past acquisitions. That's normal for Arlo. What isn't normal yet is an expense trajectory that slows relative to revenue.

Guidance, Tariffs, And The Fine Print

Arlo raised full-year 2026 revenue guidance to $580–$600 million, up from the prior range. Non-GAAP EPS guidance sits at $0.90–$1.00 for the year. Q3 revenue is guided at $140–$150 million.

The fine print matters. The $0.28 non-GAAP EPS in Q2 included a $0.07 tariff-refund benefit. Management signaled it plans to reinvest the full-year tariff refund into growth initiatives rather than hold it as incremental earnings. That means the guidance range already reflects this reinvestment decision, and investors shouldn't count the tariff refund as persistent earnings power.

Arlo also completed the acquisition of Aloe Care Health during the quarter and announced an AI-powered wellness partnership with Home Helpers Home Care. First-half acquisition-related cash outflow totaled $48.2 million. That adds execution risk and integration cost to a company still working on expense discipline at the core business.

Valuation After The Rally

Arlo's market cap sits at $1.68 billion, with an enterprise value of $1.54 billion after accounting for cash. The stock trades at 2.86 times trailing sales and roughly 18.5 times forward non-GAAP earnings. At a surface level, those multiples aren't outrageous for a company growing revenue at roughly 20% with expanding margins.

But the trailing EV/EBITDA multiple is 68.7x, because last year's EBITDA base was small. The multiple only compresses if EBITDA actually stays near the $30.6 million-per-quarter run rate. If operating expenses fail to bend below revenue growth, or if product margins slip, that forward multiple looks generous.

The average analyst price target is $20.67, implying roughly 34% upside from current levels. One analyst raised to $17. The stock has beaten estimates for four straight quarters — which is impressive but also means the bar has been reset. The next miss gets punished harder because the market has priced in continued acceleration.

Free cash flow has been steady. First-half free cash flow was $33.9 million, or roughly 11.1% of revenue. That supports the $22 million in share buybacks during Q2 and the acquisition spending. But cash on hand fell to $141.1 million from $166.4 million at year-end, and accounts receivable consumed $23.9 million in the quarter versus $4.2 million a year ago. Working capital is tightening.

Risks And The Catalyst Clock

Three risks stand out:

• Operating leverage hasn't arrived. Gross margins expanded by nearly 500 basis points. GAAP operating margin expanded by 10. Until OpEx growth falls below revenue growth, the earnings acceleration story is incomplete.
• Tariff dependency. The refund propped up Q2 non-GAAP EPS by $0.07. Management's plan to reinvest rather than retain it is the right strategic call, but it means the earnings benefit doesn't compound.
• ARR lagging account growth. If new users stay on cheaper plans, the subscription growth rate decelerates even as the account count grows.

The next proof point is Q3 earnings, which should land in late October based on Arlo's historical reporting cadence. Q3 is typically a softer quarter — the $140–$150 million revenue guide is below Q2 actuals. The question won't be whether revenue beats but whether operating expenses show discipline during a lower-revenue period. That's where the margin story either earns its credibility or cracks.

Bottom Line

Arlo is executing. Revenue growth is accelerating, margins are at records, product losses are nearly gone, and management raised guidance. But the stock rallied hard on this quarter, operating expenses are still growing faster than revenue, and the valuation now requires continued execution to justify. The cheap-entry window has closed. I'm maintaining a Hold and waiting to see if Q3 demonstrates the operating leverage the market now expects.

What would move this to a Buy: a quarter where operating expenses grow slower than revenue while paid-account ARPU stabilizes or improves. What would push it to a Sell: consecutive quarters of flat or declining ARR growth, a slip in product margins back into meaningful losses, or guidance that comes in below the raised range.